The multi-institutional symposium will cover cardiovascular toxicities, risk stratification, and include case presentations. (for providers & researchers)
The burden of care after breast cancer treatment is on oncologists, other specialists & primary care providers. Here's a new Duke-edited guide for treating survivors.
The Duke Cardio-Oncology program hosts a webinar on identifying and managing cardio-toxicities in patients undergoing cancer treatment. CE is available.
For breast cancer patient Erin Hatcher, participating in a research study to learn about the potential for heart-related side effects of chemotherapy is a “win-win” situation to protect her health in the future.
Susan Dent, MD, co-director of the Duke Cardio-Oncology Program, is a leading international expert in the field. She is also associate director of Clinical Research in DCI's Breast Program.
Susan Dent, MD, FRCPC, is the new co-leader of Duke’s efforts in cardio-oncology and new associate director of breast cancer clinical research. She joined DCI in September 2018.
Cardiologist Chiara Melloni became interested in the emerging field of cardio-oncology after her father developed heart problems while being treated for lung cancer.
Duke Cancer Institute breast oncologist Gretchen Kimmick, MD, MS, is chief editor of a new textbook — “Cardio-Oncology: The Clinical Overlap of Cancer...
Medical oncologist Susan F. Dent, MD, FRCPC, was recently named associate director for clinical research for Breast Oncology and co-director of Duke C...